1.65
-0.19(-10.33%)
Currency In USD
| Previous Close | 1.84 |
| Open | 1.96 |
| Day High | 2 |
| Day Low | 1.64 |
| 52-Week High | 11.46 |
| 52-Week Low | 1.08 |
| Volume | 104,693 |
| Average Volume | 244,357 |
| Market Cap | 33.4M |
| PE | -1.29 |
| EPS | -1.28 |
| Moving Average 50 Days | 2.27 |
| Moving Average 200 Days | 3.13 |
| Change | -0.19 |
If you invested $1000 in Envoy Medical, Inc. (COCH) since IPO date, it would be worth $169.06 as of December 21, 2024 at a share price of $1.65. Whereas If you bought $1000 worth of Envoy Medical, Inc. (COCH) shares 2 years ago, it would be worth $165.33 as of December 21, 2024 at a share price of $1.65.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss
GlobeNewswire Inc.
Dec 16, 2024 2:00 PM GMT
WHITE BEAR LAKE, Minnesota , Dec. 16, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on providing hearing loss suffers with innovative solutions today announces four new patents. T
Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication
GlobeNewswire Inc.
Nov 12, 2024 2:25 PM GMT
Study in Otology & Neurotology outlines early experiences and potential benefits of breakthrough fully implanted cochlear implant WHITE BEAR LAKE, Minnesota , Nov. 12, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”
Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System
GlobeNewswire Inc.
Nov 08, 2024 2:25 PM GMT
WHITE BEAR LAKE, Minnesota, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, today announces that the European Patent Office has granted